Unknown

Dataset Information

0

Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.


ABSTRACT:

Background

Proteinuria monitoring is required in patients receiving lenvatinib, however, current methodology involves burdensome overnight urine collection.

Methods

To determine whether the simpler urine protein:creatinine ratio (UPCR) calculated from spot urine samples could be accurately used for proteinuria monitoring in patients receiving lenvatinib, we evaluated the correlation between UPCR and 24-hour urine protein results from the phase 3 REFLECT study. Paired data (323 tests, 154 patients) were analysed.

Results

Regression analysis showed a statistically significant correlation between UPCR and 24-hour urine protein (R2: 0.75; P < 2 × 10-16). A UPCR cut-off value of 2.4 had 96.9% sensitivity, 82.5% specificity for delineating between grade 2 and 3 proteinuria. Using this UPCR cut-off value to determine the need for further testing could reduce the need for 24-hour urine collection in ~74% of patients.

Conclusion

Incorporation of UPCR into the current algorithm for proteinuria management can enable optimisation of lenvatinib treatment, while minimising patient inconvenience.

Clinical trial registration

NCT01761266.

SUBMITTER: Evans TRJ 

PROVIDER: S-EPMC6738107 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8942830 | biostudies-literature
| S-EPMC8918683 | biostudies-literature
| S-EPMC3503330 | biostudies-literature
| S-EPMC7146571 | biostudies-literature
| S-EPMC6401114 | biostudies-literature
| S-EPMC8801121 | biostudies-literature
| S-EPMC8845447 | biostudies-literature
| S-EPMC3700702 | biostudies-literature
| S-EPMC9664040 | biostudies-literature
| S-EPMC4073156 | biostudies-literature